Published in J Immunother on May 15, 2008
Immunotherapy of cancer in 2012. CA Cancer J Clin (2012) 2.12
Therapeutic cancer vaccines: are we there yet? Immunol Rev (2011) 1.86
In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles. Proc Natl Acad Sci U S A (2011) 1.38
Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host. Mol Ther (2009) 1.36
DNA vaccines: developing new strategies against cancer. J Biomed Biotechnol (2010) 1.12
Trial watch: DNA vaccines for cancer therapy. Oncoimmunology (2013) 1.11
Synthetic Nanoparticles for Vaccines and Immunotherapy. Chem Rev (2015) 1.10
A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors. J Immunother (2011) 1.02
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients. Eur J Immunol (2012) 1.01
Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination. Adv Funct Mater (2013) 0.91
DNA vaccines, electroporation and their applications in cancer treatment. Hum Vaccin Immunother (2015) 0.89
Is the "3+3" dose-escalation phase I clinical trial design suitable for therapeutic cancer vaccine development? A recommendation for alternative design. Clin Cancer Res (2014) 0.88
Lymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumors. Clin Cancer Res (2009) 0.88
Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the art. Semin Immunol (2010) 0.87
DNA vaccine for cancer immunotherapy. Hum Vaccin Immunother (2014) 0.87
Intralymphatic immunotherapy. World Allergy Organ J (2015) 0.86
Preclinical and clinical development of DNA vaccines for prostate cancer. Urol Oncol (2013) 0.86
Specific roles of each TCR hemichain in generating functional chain-centric TCR. J Immunol (2015) 0.84
Multiple vaccinations: friend or foe. Cancer J (2011) 0.83
New routes for allergen immunotherapy. Hum Vaccin Immunother (2012) 0.81
Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunity. J Transl Med (2010) 0.80
DNA vaccination: using the patient's immune system to overcome cancer. Clin Dev Immunol (2010) 0.80
ProtEx technology for the generation of novel therapeutic cancer vaccines. Exp Mol Pathol (2009) 0.79
Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model. Cancer Gene Ther (2014) 0.77
Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma. J Clin Oncol (2004) 4.09
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group. J Clin Oncol (2008) 3.58
Phase I/II study of ipilimumab for patients with metastatic melanoma. J Clin Oncol (2008) 2.79
Benign retroperitoneal schwannoma: a case series and review of the literature. Urology (2003) 2.62
Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies. J Clin Oncol (2005) 2.53
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma. J Clin Oncol (2002) 2.26
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol (2009) 2.05
Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial. Crit Care Med (2008) 1.71
Mechanical circulatory support after paediatric heart transplantation. Eur J Cardiothorac Surg (2012) 1.49
Development and analysis of a new certifying examination in perioperative transesophageal echocardiography. Anesth Analg (2002) 1.46
Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain (2002) 1.44
Experienced saxophonists learn to tune their vocal tracts. Science (2008) 1.39
The missing intra-aortic balloon pump catheter. Ital Heart J (2005) 1.39
Research governance: impeding both research and teaching? A survey of impact on undergraduate research opportunities. Med Educ (2007) 1.36
The Na+/Ca2+ exchange molecule: an overview. Ann N Y Acad Sci (2002) 1.28
Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma. Clin Cancer Res (2010) 1.19
Antigen kinetics determines immune reactivity. Proc Natl Acad Sci U S A (2008) 1.17
HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med (2005) 1.14
Vocal tract resonances in singing: the soprano voice. J Acoust Soc Am (2004) 1.13
Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma. Cancer (2003) 1.08
The landmark approval of Provenge, what it means to immunology and "in this issue": the complex relation between vaccines and autoimmunity. Int Rev Immunol (2010) 1.07
Left ventricular outflow tract obstruction caused by accessory mitral valve tissue. J Am Soc Echocardiogr (2006) 1.07
Phase I trial of imexon in patients with advanced malignancy. J Clin Oncol (2007) 1.07
Acoustics: tuning of vocal tract resonance by sopranos. Nature (2004) 1.05
Intra-lymph node prime-boost vaccination against Melan A and tyrosinase for the treatment of metastatic melanoma: results of a phase 1 clinical trial. Clin Cancer Res (2011) 1.04
A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors. J Immunother (2011) 1.02
Naturally acquired simian varicella virus infection in African green monkeys. J Virol (2002) 1.01
Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination. J Clin Invest (2002) 0.99
Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration. Eur J Immunol (2005) 0.98
Vasculotoxic effects of insulin and its role in atherosclerosis: what is the evidence? Curr Atheroscler Rep (2011) 0.98
Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus. Vaccine (2003) 0.97
Physiological predictors of survival during high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome. Crit Care (2013) 0.95
Efficacy and time-efficiency of a "sonographer-driven" contrast echocardiography protocol in a high-volume echocardiography laboratory. Am Heart J (2003) 0.95
Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross-sectional survey in China. Eur J Haematol (2007) 0.95
Recombinant immunoglobulin-based epitope delivery: a novel class of autoimmune regulators. Int Rev Immunol (2005) 0.95
Mycophenolate mofetil decreases antibody production after cardiac transplantation. J Heart Lung Transplant (2002) 0.94
Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples. Clin Med Insights Pathol (2012) 0.94
The role of the CTLA4 blockade in the treatment of malignant melanoma. Cancer Invest (2007) 0.93
Anti-intercellular adhesion molecule-1 antibodies in sera of heart transplant recipients: a role in endothelial cell activation. Transplantation (2005) 0.93
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer. Invest New Drugs (2009) 0.92
Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides. Vaccine (2009) 0.90
Preclinical antitumor activity, pharmacokinetics and pharmacodynamics of imexon in mice. Anticancer Drugs (2006) 0.89
New section in journal of translational medicine: patient-targeted molecular therapies. J Transl Med (2012) 0.88
Lymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumors. Clin Cancer Res (2009) 0.88
A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors. Clin Cancer Res (2005) 0.88
A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma. Clin Cancer Res (2003) 0.88
The clarinet: how blowing pressure, lip force, lip position and reed "hardness" affect pitch, sound level, and spectrum. J Acoust Soc Am (2013) 0.86
The kinetics and acoustics of fingering and note transitions on the flute. J Acoust Soc Am (2009) 0.86
Acoustics: the vocal tract and the sound of a didgeridoo. Nature (2005) 0.86
Student-selected components in the undergraduate medical curriculum: a multi-institutional consensus on purpose. Med Teach (2004) 0.86
Pediatric patient surface doses in neuroangiography. Pediatr Radiol (2005) 0.86
Array analysis of simian varicella virus gene transcription in productively infected cells in tissue culture. J Virol (2005) 0.85
Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safety. Eur J Immunol (2002) 0.85
Heat denaturation, a simple method to improve the immunotherapeutic potential of allergens. Eur J Immunol (2005) 0.84
An HPLC method for the measurement of 5-fluorouracil in human plasma with a low detection limit and a high extraction yield. Int J Mol Med (2002) 0.84
Expression of a vitelline membrane protein, BmVMP23, is repressed by bmo-miR-1a-3p in silkworm, Bombyx mori. FEBS Lett (2013) 0.83
Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity. Pharmacogenet Genomics (2007) 0.83
A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma. Cancer (2010) 0.83
A new era in cancer immunotherapy: discovering novel targets and reprogramming the immune system. Int Rev Immunol (2015) 0.82
Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy. Crit Care (2008) 0.82
Immune responsiveness, tolerance and dsRNA: implications for traditional paradigms. Trends Immunol (2003) 0.82
Scoliosis research society-22 results in 3052 healthy adolescents aged 10 to 19 years. Spine (Phila Pa 1976) (2014) 0.81
Lack of adult-type salivary cortisol circadian rhythm in hospitalized preterm infants. Horm Res (2005) 0.81
Cardiac Troponin Release is Associated with Biomarkers of Inflammation and Ventricular Dilatation During Critical Illness. Shock (2016) 0.81
Student-selected components in the undergraduate medical curriculum: a multi-institutional consensus on assessable key tasks. Med Teach (2005) 0.81
TLR-9 signaling and TCR stimulation co-regulate CD8(+) T cell-associated PD-1 expression. Immunol Lett (2009) 0.81
Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunity. J Transl Med (2010) 0.80
Celiac disease: progress towards diagnosis and definition of pathogenic mechanisms. Int Rev Immunol (2011) 0.80
New electric-field-driven mesoscale phase transitions in polarized suspensions. Phys Rev Lett (2005) 0.80
Cryopreservation of economically valuable marine micro-algae in the classes Bacillariophyceae, Chlorophyceae, Cyanophyceae, Dinophyceae, Haptophyceae, Prasinophyceae, and Rhodophyceae. Cryobiology (2006) 0.79
The Th17 cell population and the immune homeostasis of the gastrointestinal tract. Int Rev Immunol (2013) 0.79
The role of coronary angiography in acute type A aortic dissection. Eur J Cardiothorac Surg (2004) 0.79
Rational design of solid aerosols for immunoglobulin delivery by modulation of aerodynamic and release characteristics. J Control Release (2004) 0.79
Editorial: international reviews of immunology. Int Rev Immunol (2014) 0.79
Saxophonists tune vocal tract resonances in advanced performance techniques. J Acoust Soc Am (2011) 0.79
Comparison of energy expenditure, economy, and pedometer counts between normal weight and overweight or obese women during a walking and jogging activity. Eur J Appl Physiol (2009) 0.78
Molecular cloning and characterization of hatching enzyme-like geneII (BmHELII) in the silkworm, Bombyx mori. Biochem Biophys Res Commun (2012) 0.78
Vocal tract resonances in singing: Strategies used by sopranos, altos, tenors, and baritones. J Acoust Soc Am (2011) 0.78
Assessment of regional lung mechanics with electrical impedance tomography can determine the requirement for ECMO in patients with severe ARDS. Intensive Care Med (2012) 0.77
Experimental evaluation of inverse filtering using physical systems with known glottal flow and tract characteristics. J Acoust Soc Am (2013) 0.77
Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II study. Invest New Drugs (2004) 0.77
Low-complexity PDE-based approach for automatic microarray image processing. Med Biol Eng Comput (2014) 0.77
Effect of ABCB1 genotype on pre- and post-cardiac transplantation plasma lipid concentrations. J Cardiovasc Transl Res (2011) 0.77
Effects of bisphenol A on chlorophyll synthesis in soybean seedlings. Environ Sci Pollut Res Int (2014) 0.77
In this issue: Tec kinases in the crosshairs. Int Rev Immunol (2012) 0.77
The effect of whisper and creak vocal mechanisms on vocal tract resonances. J Acoust Soc Am (2010) 0.77